Selecting COVID‐19 convalescent plasma for neutralizing antibody potency using a high‐capacity SARS‐CoV‐2 antibody assay

BACKGROUND: Efficacy of COVID‐19 convalescent plasma (CCP) is hypothesized to be associated with the concentration of neutralizing antibodies (nAb) to SARS‐CoV‐2. High capacity serologic assays detecting binding antibodies (bAb) have been developed; nAb assays are not adaptable to high‐throughput te...

Full description

Saved in:
Bibliographic Details
Published in:Transfusion
Main Authors: Goodhue Meyer, Erin, Simmons, Graham, Grebe, Eduard, Gannett, Michael, Franz, Sergej, Darst, Orsolya, Di Germanio, Clara, Stone, Mars, Contestable, Paul, Prichard, Alicia, Reik, Rita, Vassallo, Ralph, Young, Pampee, Busch, Michael P., Williamson, Phillip, Dumont, Larry J.
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Inc. 2021
Subjects:
Donor Infectious Disease Testing
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8013397/
https://ncbi.nlm.nih.gov/pubmed/33554362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.16321
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items